Abstract
The insatiable appetite for safer more effective, but increasingly more expensive, therapy in the face of increasing government reluctance to feed this demand has put the study of drug utilization and pharmacoeconomics centre stage. Clinical pharmacologists are uniquely positioned to determine the cost benefit and utility of modern therapy and give impartial advice on safe, effective and economic patient care. To mark the Quatercentenary Celebrations of Trinity College Dublin, eight speakers addressed this theme in a symposium held in conjunction with the British Pharmacological Society Meeting in July 1992.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Feely J. The influence of pharmacoeconomic factors on prescribing patterns in Ireland. Pharmacoeconomics. 1992 Aug;2(2):99–106. doi: 10.2165/00019053-199202020-00003. [DOI] [PubMed] [Google Scholar]
- Ferrando C., Henman M. C., Corrigan O. I. Impact of a nationwide limited prescribing list: preliminary findings. Drug Intell Clin Pharm. 1987 Jul-Aug;21(7-8):653–658. doi: 10.1177/1060028087021007-819. [DOI] [PubMed] [Google Scholar]
- Hammel R. W. Insights into public assistance medical care expenditures. JAMA. 1972 Mar 27;219(13):1740–1744. [PubMed] [Google Scholar]
- Soumerai S. B., Ross-Degnan D., Gortmaker S., Avorn J. Withdrawing payment for nonscientific drug therapy. Intended and unexpected effects of a large-scale natural experiment. JAMA. 1990 Feb 9;263(6):831–839. [PubMed] [Google Scholar]